Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)

ClinicalTrials.gov ID: NCT04745351

Public ClinicalTrials.gov record NCT04745351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for COVID-19

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate whether remdesivir (RDV, GS-5734™) reduces the composite risk of death or invasive mechanical ventilation (IMV) through Day 29 in participants with severely reduced kidney function who are hospitalized for coronavirus disease 2019 (COVID-19).

Study identification

NCT ID
NCT04745351
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
249 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2021 (Actual)
Primary completion
Apr 20, 2022 (Actual)
Completion
May 24, 2022 (Actual)
Last update posted
May 12, 2023

2021 – 2022

United States locations

U.S. sites
41
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
St. Vincent's Health System Birmingham Alabama 35205 —
UAB Hospital Birmingham Alabama 35294 —
Pulmonary Associates of Mobile, P.C. Mobile Alabama 36608 —
St. Joseph Hospital Eureka Eureka California 95501 —
Hoag Memorial Hospital Presbyterian, 16200 Sand Canyon Ave Irvine California 92618 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
Sutter Medical Center Sacramento Sacramento California 95816 —
Torrance Memorial Medical Center Torrance California 90505 —
MedStar Health Research Institute Washington D.C. District of Columbia 20010 —
George Washington Medical Faculty Associates Washington D.C. District of Columbia 20037 —
North Florida/ South Georgia Veterans Health System Gainesville Florida 32608 —
Mayo Clinic Florida Jacksonville Florida 32224 —
Genesis Clinical Research Tampa Florida 33603 —
Northwestern Medicine Central DuPage Hospital Winfield Illinois 60190 —
Baptist Health Lexington Lexington Kentucky 40503 —
Tulane Medical Center, 2000 Canal St. New Orleans Louisiana 70112 —
Tulane Medical Center New Orleans Louisiana 70112 —
Wake Forest University Health Sciences Bethesda Maryland 20892 —
Holy Cross Hospital, 19801 Observation Dr Germantown Maryland 20876 —
Holy Cross Hospital Silver Spring Maryland 20910 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Newton-Wellesley Hospital Newton Massachusetts 02462 —
St. Clair Nephrology Research Grosse Pointe Woods Michigan 48236 —
G.V. (Sonny) Montgomery VAMC Jackson Michigan 39216 —
Mayo Clinic Hospital Rochester Minnesota 55902 —
Saint Michael's Medical Center Newark New Jersey 07102 —
University of New Mexico Hospital Albuquerque New Mexico 87131 —
New York - Presbyterian Hospital/Weill Cornell Medical Center New York New York 10065 —
Stony Brook University Hospital Stony Brook New York 11716 —
Jacobi Medical Center The Bronx New York 10461 —
PMG Infectious Disease Consultants (administrative) Portland Oregon 92775 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Medical University of South Carolina Charleston South Carolina 92037 —
Houston Methodist Hospital Houston Texas 77030 —
Memorial Hermann Hospital at TMC Houston Texas 77030 —
VCU Health Medical Center Richmond Virginia 23298 —
Providence Regional Medical Center Everett Everett Washington 98201 —
Swedish Medical Center Seattle Washington 98122 —
Providence Health Care Spokane Washington 99204 —
Providence Health Care, 5633 N Lidgerwood Spokane Washington 99208 —
MultiCare Good Samaritan Hospital Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04745351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2023 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04745351 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →